Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016

October 21, 2020 • 01:04:57
Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016
MitoAction Expert Series
Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016

Oct 21 2020 | 01:04:57

/

Show Notes

Dr. Amy Goldstein provides an update on the Mitochondrial Medicine Society.

Areas of discussion include:

Centers of Excellence and the need for community involvement/input

About the Speaker

Dr. Amy Goldstein, a member of the Board of Trustees of UMDF, is on faculty at Children’s Hospital of Pittsburgh of UPMC in the Division of Pediatric Neurology. She is board certified in pediatrics, neurology, and psychiatry with Special Qualifications in Child Neurology. She is currently an Assistant Professor at the University of Pittsburgh School of Medicine. She began a multidisciplinary Mitochondrial Disease clinic in 2007 and is now the Director of Neurogenetics & Metabolism and the site Principle Investigator for NAMDC (the North American Mitochondrial Disease Consortium). She is also President of the Mitochondrial Medicine Society. Her clinical research interests include improving fatigue and exercise intolerance as well as developing common patient-centered outcome measures for clinical trials.

 

To view the accompanying slides, click here.

Other Episodes

Episode

November 21, 2025 • 01:20:23
Episode Cover

Understanding Rare Genetic Variants: What Do My Results Really Mean?

When a genetic variant is shared by only a handful of individuals worldwide, what does it mean for diagnosis, treatment, and research? In this...

Listen

Episode

June 08, 2026 • 01:31:54
Episode Cover

Neuropathy and Disorders of Mitochondrial Dysfunction

Dr. Amy Goldstein will join MitoAction to review the neurological system and the differences between types of neuropathies. She will explore what conditions neuropathy...

Listen

Episode 58

November 05, 2021 • 01:27:22
Episode Cover

Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.

Join MitoAction and Dr. Richard Boles for our November Mito Expert Series presentation titled: Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear...

Listen